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The genomic RNA of rubella virus contains two long open reading frames (ORF), a 59-proximal ORF that codes for the
nonstructural proteins and a 39-proximal ORF that encodes the structural proteins. The cDNA encoding the nonstructural
protein ORF of the wild-type M33 strain of rubella virus has been obtained and sequenced. Comparison between the
nonstructural proteins of the M33 and Therien strains of rubella virus revealed a 98% homology in nucleotide sequence and
98.1% in deduced amino acid sequence. To examine the processing of rubella virus nonstructural protein, the complete
nonstructural protein ORF was expressed in BHK cells using a pSFV expression vector. Three nonstructural protein products
(p200, p150, and p90) with molecular weights of 200, 150, and 90 kDa were identified using antisera raised against synthetic
peptides corresponding to regions of the nonstructural proteins. p200 is the polyprotein precursor, while p150 and p90 are
the cleavage products. Site-directed mutagenesis of the Cys-1151 residue (one of the catalytic dyad residues of the viral
protease) and of the Gly-1300 residue (the viral protease cleavage site) abrogated protease activity and p200 precursor
cleavage, respectively. Coexpression of mutant constructs in BHK cells indicated that rubella virus protease can function
both in cis and in trans. © 1998 Academic Press
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INTRODUCTION
Rubella virus (RV) is an enveloped, positive-strand
RNA virus in the family Togaviridae (Francki et al., 1991).
It is the sole member of the genus Rubivirus and bears
striking similarities to the alphaviruses, such as Semliki
Forest virus (SFV) and Sindbis virus (SV), in terms of
genome organization and structural protein expression
strategy (Strauss and Strauss, 1994). However, unlike
alphaviruses, RV infection in cultured cells is character-
ized by a relatively long latency period, slow replication,
and limited cytopathology and does not shut off host cell
macromolecular synthesis (Hemphill et al., 1988). Prob-
lems of slow replication and low virus yield have ham-
pered progress regarding the molecular details of RV
replication.
In the RV virion the icosahedral nucleocapsid is com-
posed of a single copy of the 40S genomic RNA and
multiple copies of the capsid protein (C, 33 kDa). This is
surrounded by a lipid bilayer into which two viral glyco-
proteins, E1 (57 kDa) and E2 (42–47 kDa), are embedded
(Oker-Blom et al., 1983). In addition to the 40S genomic
RNA, RV-infected cells contain a 24S subgenomic RNA
that is derived from the 39 end of the 40S genomic RNA
(Oker-Blom et al., 1984). Upon infection, the genomic
RNA serves as both the mRNA for synthesis of the viral
nonstructural proteins and the template for synthesis of
complementary minus-strand RNA. Newly synthesized
minus-strand RNA in turn functions as the template for
both synthesis of plus-strand genomic RNAs and tran-
scription of subgenomic RNAs, which are translated to
produce the three viral structural proteins, C, E2, and E1
(Oker-Blom et al., 1984).
Although the translation and processing of the struc-
tural proteins of RV have been studied in detail, little is
known about the translation and processing of the non-
structural proteins (ns proteins). Bowden and Westaway
(1984) demonstrated that there were four prominent spe-
cies of RV-specific ns proteins (200, 150, 87, and 75 kDa);
the 200-kDa species is the polyprotein precursor and the
150-kDa protein was derived from the 200-kDa precursor.
Recently, when a cDNA containing the coding region of
the ns proteins of RV was introduced into a vaccinia
expression vector, three RV-specific proteins with molec-
ular sizes of 200, 150, and 90 kDa were observed (Marr
et al., 1994).
Comparative amino acid sequence analyses of pro-
teins involved in the replication of positive-strand RNA
viruses, together with functional analyses of a few of
these proteins, have allowed identification of amino acid
sequence motifs for RNA replicases, RNA helicases,
proteases, and RNA methyltransferases. The sequence
motifs identified by these studies have allowed localiza-
tion of sequences in RV ns polyprotein that are respon-
sible for each of these functions. The p150 contains the
amino-terminal sequences of the polyprotein and the
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proposed methyltransferase and protease sequences at
its amino and carboxy terminus, respectively (Marr et al.,
1994). The p90 contains the predicted helicase and RNA
polymerase sequences at its amino- and carboxy-termi-
nal regions, respectively (Dominguez et al., 1990). Exper-
imental evidence for the protease (Chen et al., 1996) and
helicase (Gros and Wengler, 1996) activities of the pro-
posed regions has been obtained. It has been demon-
strated that RV p150 possesses a papain-like cysteine
protease activity (Marr et al., 1994), with the catalytic
dyad residues of Cys-1151 and His-1272 and the pro-
tease cleavage site within Gly-1300–Gly-1301 (Chen et
al., 1996).
Understanding the mechanism of RNA virus replica-
tion is of prime significance because of its central role in
the pathogenicity of a large group of viruses. Despite its
importance, very little is known about the details of this
replication process in higher eukaryotic cells. In order to
study the replication mechanism of RV, we have cloned
and expressed RV ns protein genes in BHK cells. We
report here our studies on the cloning, sequencing, ex-
pression, and proteolytic cleavage of RV ns protein. A
pSFV-1 eukaryotic expression system, based on the SFV
replicon (Liljestrom and Garoff, 1991), was used in this
study. Identification of RV ns proteins was carried out by
using rabbit antisera raised against six synthetic pep-
tides corresponding to different regions of RV ns pro-
teins. To investigate the ability of RV protease to function
in cis or in trans, several mutant constructs were gener-
ated. Coexpression studies indicate that RV protease
can function both in cis and in trans.
RESULTS
Sequence analysis and comparison between M33
and Therien strains
Sequence analysis of the RV ns protein genes (M33
strain) revealed a long open reading frame (ORF) of 6345
nucleotides with an AUG initiation codon beginning at nu-
cleotide 41 and terminating at nucleotide 6385 with an
ochre (UAA) stop codon which was followed by two further
in-frame ochre stop codons at nucleotides 6410 and 6425,
respectively (EMBL Accession No. X72393RVM33NP). This
ORF differs from that reported for the Therien strain, in
which the 59-proximal ORF is 6615 nucleotides in length
and terminates at position 6656 with an opal codon (UGA)
which is followed 12 nucleotides downstream by a second
inframe opal codon (Dominguez et al., 1990). This ORF
overlaps with the 39-proximal ORF beginning at nucleotide
6507 (Dominguez et al., 1990). This difference was due to a
sequencing error in the Therien strain (omission of two
nucleotides (CG) at position 6292). With these two addi-
tional nucleotides, the 59-proximal ORF would use different
termination codons than originally deduced in the Therien
strain (Dominguez et al., 1990). The corrected termination
codons would be identical to those of the M33 strain re-
ported here. This sequencing error in the Therien strain has
been corrected (Pugachev et al., 1997).
Comparison of the ns protein ORF between M33 and
Therien strains revealed a 98% homology in nucleotide
sequence and 98.1% in deduced amino acid sequence.
We have also determined the 59 end of the genomic RNA
of M33 strain by poly(A) tailing of cDNA followed by PCR
amplification. The sequence obtained from the amplified
product is shown in Fig. 1. The sequence GTTAC, down-
stream of poly(A), is complementary to CAATG of the 59
terminus of the cDNA of the genomic RNA. Therefore, the
RV M33 strain also has the same 59-terminal sequence
as that reported in the Therien strain (Wang et al., 1994).
Expression of RV ns proteins in transfected BHK cells
The pSFV-1 eukaryotic expression vector (Liljestrom
and Garoff, 1991) is a novel DNA expression system
based on the SFV replicon, which has a broad host range
and a high level of expression efficiency. To study the
processing of the RV ns protein, a cDNA containing the
RV ns protein ORF was inserted into the SmaI site of the
pSFV-1 vector. Recombinant plasmid (pSFV/RVnsp) (Fig.
2) linearized at the SpeI site was used for the synthesis
of RNA transcripts using phage SP6 RNA polymerase.
BHK cells were transfected with synthesized RNA tran-
scripts by electroporation. After 24 h posttransfection,
BHK cells were labeled with [35S]methionine/cysteine
and 35S-labeled cellular lysates were immunoprecipi-
tated with antisera raised against synthetic peptides
corresponding to the amino acid sequence of the RV ns
FIG. 1. The 59-terminal sequence of RV genomic RNA. RV virion RNA
was used as template in the first-strand cDNA synthesis. The 39-
terminally poly(A)-tailed cDNA was used as a template in PCR ampli-
fication as described under Materials and Methods. The DNA se-
quence downstream from the A tract is shown at the right of the gel.
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protein (Fig. 2). Three ORF-specific proteins, p200, p150,
and p90 (molecular masses of 200, 150, and 90 kDa,
respectively), were identified using peptide antisera
(NS1, NS2, NS4, NS5, and NS6) (Fig. 3A). In BHK cells
transfected with the pSFV-1 vector, no specific protein
species with molecular sizes of 200, 150, and 90 kDa
were immunoprecipitated by any of the antisera (Fig. 3A,
lanes 1, 3, 5, 7, 9, and 11). The failure of peptide antiserum
NS3 to immunoprecipitate any specific ns protein prod-
ucts may be due to the low affinity of this antiserum.
Aside from this failure the recognition of p200 by all of
the antisera indicates that p200 is the polyprotein pre-
cursor, and p150 and p90 are the cleavage products of
p200. Since p150 was immunoprecipitated by antisera
NS1, NS2, and NS4, whereas p90 was recognized by
antisera NS5 and NS6, the order of the cleavage prod-
ucts is NH2-150-90-COOH. This is consistent with the
finding of Forng and Frey (1995). As peptide antisera NS1
and NS5 were found to give higher titers than the other
antisera, they were used for the studies reported below.
To further examine the processing of RV ns protein, the
transfected BHK cells were pulse-labeled for 40 min and
chased for the indicated time periods prior to lysis. After
a 40 min of pulse labeling, p150 (Fig. 3B, lane 3) and p90
(Fig. 3B, lane 4) were detected (Fig. 5B, lanes 3 and 4),
indicating that the cleavage of p200 is quite efficient.
Chased with excess unlabeled methionine and cysteine,
the intensities of bands corresponding to p150 and p90
increased, whereas that for p200 decreased after a 120-
min chase (Fig. 3B, lanes 5 to 10). The other protein
species with molecular weights of 170, 130, and 110 kDa
(indicated as dots) could be the degraded products of ns
proteins or nonspecific host proteins coprecipitated with
the ns protein.
trans processing of ns protein
According to the prediction of Gorbalenya et al.
(1991), RV protease belongs to the family of Main or
M-protease that exhibits trans activity and mediates
viral RNA replication and expression. However, it has
been shown that when part of the RV ns protein ORF
containing the protease domain and its cleavage site
(nucleotides 2515 to 4560) was expressed in BHK cells
by using a Sindbis virus vector (Bredenbeek and Rice,
1992), no trans cleavage activity was detected in co-
expression studies (Chen et al., 1996). To determine
whether the lack of trans cleavage activity is due to the
deletion at either the 59 or the 39 end of p200, we have
FIG. 3. Expression of RVnsp ORF in pSFV/RVnsp-transfected BHK
cells. (A) BHK cells were transfected with a pSFV-1 vector (lanes 1, 3, 5,
7, 9, and 11) or pSFV/RVnsp (lanes 2, 4, 6, 8, 10, and 12). Transfected
cells were labeled with [35S]methionine/cysteine for 60 min and cellular
lysates were immunoprecipitated with peptide antisera (NS1 to NS6).
Positions of nsp ORF-specific products (200, 150, and 90 kDa) are
marked on the right. Molecular weight standards (in kDa) are indicated
on the left. (B) BHK cells were transfected with a pSFV vector (lanes 1
and 2) or with pSFV/RVnsp (lanes 3 to 10), pulsed labeled with [35S]me-
thionine/cysteine for 40 min, and chased for the indicated time periods.
Cellular lysates were immunoprecipitated with antisera NS1 (lanes 1, 3,
5, 7, and 9) or NS5 (lanes 2, 4, 6, 8, and 10). RV-specific ns proteins are
indicated on the right. Molecular weight standards (in kDa) are indi-
cated on the left.
FIG. 2. Schematic representation of pSFV/RVnsp mutants and re-
gions of the NSP ORF corresponding to the synthetic peptides. The RV
sequences within the NSP ORF are shown with a number line in
kilobases. Numbers below line in the diagram represent nucleotides in
RV genome. The mutation resulting in a Cys to Ser or a Gly to Ser
conversion in the pSFV/RVnsp construct is indicated (). The deletion
mutants D90 and D150 were constructed as described under Materials
and Methods. The regions corresponding to the synthetic peptides
(NS1, NS2, NS3, NS4, NS5, and NS6) are indicated above the diagram
representing the RV genome. S, SphI; X, XbaI; B, BgIII; N, NcoI; H,
HindIII; and E, EcoRI.
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constructed four mutants in ns protein ORF. pSFV/Cys-
1151, a protease-inactivated mutant carrying a cys-
teine to serine mutation at residue 1151; pSFV/Gly-
1300, a cleavage site mutant carrying a glycine to
serine mutation at residue 1300; pSFV/D90, a deletion
mutant in which part of the coding region of p90 at the
39 end of p200 was deleted; and pSFV/D150, a deletion
mutant in which 918 amino acid residues (nucleotides
39 to 2794) at the 59 end of p200 were deleted (Fig. 2).
As expected, changing glycine to serine at residue
1300 resulted in the complete abolition of cleavage; no
cleavage product was detected after a 60-min chase
(Fig. 4A, lanes 7 and 8). This cleavage-blocked mutant
(pSFV/Gly-1300) was used as a source of protease in
cotransfection experiments with protease-inactivated
mutant (pSFV/Cys-1151) which provide p200 as a source
of substrate. After a 40-min pulse labeling, p200 precur-
sor and its cleavage products (p150 and p90) were ob-
served (Fig. 4B, lanes 1 and 2), and the intensity of p150
and p90 bands increased after a 60-min chase (Fig. 4B,
lanes 3 and 4). Since no cleavage products were de-
tected when BHK cells were transfected alone with ei-
ther pSFV/Cys-1151 (protease-inactivated mutant) (Fig.
4C, lanes 1 to 4) or pSFV/Gly-1300 (cleavage-blocked
mutant) (Fig. 4A, lanes 5 to 8), the detection of cleavage
products in the cotransfection experiments indicates that
trans processing had occurred. To further confirm the
trans activity of RV protease, we used a 39-end deletion
mutant (pSFV/D90) to serve as a source of protease in
cotransfection experiments. After a 40-min pulse label-
ing, cleavage of this deletion precursor was observed
(Fig. 4C, lanes 9 and 10). Production of the cleavage
products (150 and 50 kDa) increased after a 60-min
chase (Fig. 4C, D90, lanes 11 and 12). In the cotransfec-
FIG. 4. Analysis of trans activity of RV ns proteins. (A) BHK cells were transfected with pSFV/RVnsp (wt) or with mutant construct pSFV/Gly-1300.
Transfected BHK cells were labeled for 40 min and chased for 60 min. Cellular lysates were immunoprecipitated with antisera NS1 (lanes 1, 3, 5, and
7) or NS5 (lanes 2, 4, 6, and 8). RV-specific ns proteins are indicated on the right. (B) BHK cells were cotransfected with pSFV/Cys-1151 and
pSFV/Gly-1300 constructs. Transfected BHK cells were labeled for 40 min and chased for 60 min. Cellular lysates were immunoprecipitated with
antisera NS1 (lanes 1 and 3) or NS5 (lanes 2 and 4). RV-specific ns proteins are indicated on the right. Molecular weight standards (in kDa) are
indicated on the left. (C) BHK cells were transfected with individual mutant constructs (pSFV/Cys-1151 or pSFV/D90) or both constructs. Transfected
cells were pulse labeled for 40 min and chased for 60 min. Cellular lysates were immunoprecipitated with antisera NS1 (lanes 1, 3, 5, 7, 9, and 11)
or NS5 (lanes 2, 4, 6, 8, 10, and 12). RV-specific ns proteins are indicated on the left. Molecular weight standards (in kDa) are indicated on the right.
(D) BHK cells were transfected with individual mutant constructs (pSFV/Cys-1151 or pSFV/D150) or both constructs. Transfected cells were pulse
labeled for 40 min and chased for 60 min. Cellular lysates were immunoprecipitated with antisera NS1 (lanes 1, 3, 5, and 7) or NS5 (lanes 2, 4, 6, and
8). RV-specific ns proteins are indicated on the right. The polyprotein of D150 mutant (130 kDa) is indicated by an arrow. Molecular weight standards
(in kDa) are indicated on the left.
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tion experiments, after a 60-min chase, p90 was clearly
visible (Fig. 4C, Cys-1151/D90, lane 8). These results
clearly demonstrated that RV protease has trans activity,
although the processing in trans was slower than that of
the cis processing. To determine whether the 59-end
region upstream of the protease domain is necessary for
the trans cleavage activity, we carried out the coexpres-
sion studies using a 59-end deletion mutant (pSFV/D150)
as a source of protease and protease-inactivated mutant
(pSFV/Cys-1151) as a source of substrate. After a 40-min
pulse labeling, cleavage of the 130-kDa deletion precur-
sor (Fig. 4D, arrow) to p90 was observed (Fig. 4D, lane 6).
Due to the lack of antiserum specific to the 40-kDa
cleavage product, only p90 was immunoprecipitated by
NS5 antiserum. The intensity of the p90 band increased
after a 60-min chase (Fig. 4D, lane 8). However, in the
cotransfection experiments, no trans cleavage activity
was detected, as no p150 cleavage product was immu-
noprecipitated by NS1 antiserum (Fig. 4D, lanes 1 and 3).
The p90 product in the coexpression experiments was
the cleavage product from deletion precursor (130 kDa)
(Fig. 4D, lanes 2 and 4). This finding indicates that the
trans cleavage activity of RV protease may require the
native p150.
Processing of RV ns protein in RV-infected Vero cells
Nakhasi et al. (1988) have shown that treatment of
cells with actinomycin D either before infection or during
the eclipse period of RV infection, but not during later
periods, decreases the final yield of virus. These results
indicate that during the viral infection, host cell DNA
directs the synthesis of cellular factor(s) essential for
viral replication. When the synthesis of this cellular fac-
tor(s) is terminated at an early stage of viral infection by
actinomycin D, viral replication is impaired. To determine
the processing of the RV ns protein at different times in
the viral replication cycle and the association of host
protein(s) with the replication complexes, RV-infected
Vero cells were labeled for 3 h with [35S]methionine/
cysteine at 24 or 48 h postinfection (pi), followed by a 3-h
chase with excess unlabeled methionine and cysteine.
The monolayers were lysed with buffer containing 1%
NP-40 (without SDS) and immunoprecipitation was per-
formed as described by Wahlberg et al. (1989) using
NP-40 as a detergent. At 24 h pi, p200 was the dominant
ns protein species observed (Fig. 5A), while at 48 h pi,
p90 was the major ns protein species (Fig. 5B). The
intensity of the p90 band was much greater than that of
the p150 band and the p200 band decreased substan-
tially compared to that at 24 h pi (Fig. 5B). These results
indicate that RV ns protein processing is relatively slow
and it is possible that early in infection, the cleavage
kinetics might differ from those in late infection and that
the processing of p200 may be highly regulated during
the infectious cycle.
In our earlier studies, we have observed that our
antibodies coprecipitate other protein species besides
p200, p150, and p90. In this study, in the absence of SDS,
besides p200, p150, and p90, protein species with mo-
lecular sizes of 140, 130, and 70 kDa were co-immuno-
precipitated by antiserum NS5 (Fig. 5B, lanes 5 and 6,
dots). It is interesting that human anti-RV serum also
co-immunoprecipitated p200, p90, and the 70-kDa pro-
tein, apart from the RV structural proteins (Fig. 5, human
lane 8). It is likely that the 140- and 70-kDa protein
species were host proteins coprecipitated by antisera. At
present we do not know if these proteins are involved in
RV replication.
The compound L-trans-epoxysuccinyl-L-leucylamido
(4-guanidinobutane) (E-64) is a specific inhibitor of thiol
proteases, including the papain family of cysteine pro-
teases (Kleina and Grubman, 1992). To examine the ef-
fect of E-64 on the processing of p200, RV-infected Vero
cells (48 h postinfection) were treated with E-64 or E-64C
(an analog of E-64, trans-epoxysuccinyl-L-leucylamido-3-
FIG. 5. Immunoprecipitation of RV ns proteins in infected cells.
Monolayers of Vero cells mock-infected (lanes 1, 4 and 7) or RV-infected
(lanes 2, 3, 5, 6, 8, and 9) were labeled for 3 h at 24 h pi (A) or 48 h pi
(B) and chased for 3 h (lanes 3, 6, and 9). Monolayers were lysed with
lysis buffer containing 1% NP-40, and cellular lysates were immuno-
precipitated with antisera NS1 (lanes 1 to 3), NS5 (lanes 4 to 6), or
human anti-RV serum (lanes 7 to 9). The position of RV-specific ns
proteins and the molecular weight standards (in kDa) are indicated,
respectively, on the right and the left.
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methylbutaine) at a concentration of 0.3 mg/ml for 90
min, and labelled with [35S]methionine/cysteine for 2.5 h.
After a 2.5-h chase with excess unlabeled methionine/
cysteine, the monolayers were lysed and cellular lysates
immunoprecipitated with antisera. (E-64 and E-64C were
present in the medium during the pulse–chase period).
In control infected cells, p200 was not detected (Fig. 6,
lanes 2, 6, and 7). While in treated cells, p200 was still
present after the chase period (Fig. 6, lanes 3, 4, 8, and
9), and processing of p200 was only partially inhibited, as
p90 cleavage product was detected in the treated cells
(Fig. 6, lanes 8 and 9). It appears that RV assembly was
not affected by the treatment (data not shown). We could
not use a higher concentration of E-64 or E-64C in our
experiments (the reported range is between 0.1 and 2.0
mg/ml) (Kleina and Grubman, 1992), due to the limited
solubility of E-64 and E-64C in aqueous solution and the
inhibition of dimethyl sulfoxide on RV replication (data
not shown). In spite of this limitation, our results provide
additional evidence that RV protease belongs to the
papain family.
DISCUSSION
We have cloned and sequenced the complete ns pro-
tein genes of the RV M33 strain. Sequence analysis of
the coding region of ns protein genes revealed a long
ORF with an AUG initiation codon at nucleotide 41 and
three in-frame ochre stop codons at nucleotides 6386,
6410, and 6425, respectively. Comparison between the
ns proteins of the M33 and Therien strains of RV showed
a 98% homology in nucleotide sequence and 98.1% in
deduced amino acid sequence. Three ns protein ORF-
specific products with molecular weights of 200, 150, and
90 kDa were identified using antisera raised against
synthetic peptides corresponding to regions of ns pro-
teins of the RV M33 strain (Fig. 3). Our results are con-
sistent with the reported work of Forng and Frey (1995).
Two classes of viral papain-like protease have been
assigned on the basis of their ability to function in cis or
trans (Gorbalenya et al., 1991). Main protease cleaves
the viral polyprotein both in trans and in cis at multiple
sites within polyprotein and contains a new conserved
domain (the x domain, a novel conserved domain of
unknown function), whereas leader protease exhibits cis
activity and cleaves at single site (Gorbalenya et al.,
1991). By comparative sequence analysis, Gorbalenya et
al., (1991) proposed that RV protease is a Main protease
and bears pronounced similarity to cellular proteases.
Our studies demonstrated that RV protease is a Main
protease that can function both in cis and in trans (Fig. 4),
consistent with the prediction of Gorbalenya et al. (1991).
The failure to detect trans cleavage by the RV protease
when it was expressed as a truncated form (from resi-
dues 2515 to 4560) (Chen et al., 1996) could be due to
conformational changes induced by the deletion or the
requirement of intact p150 for the expression of trans
cleavage activity.
In general, most ns proteins of viruses arise from the
processing of a completed precursor. The protein spe-
cies responsible for the trans cleavage is not known. We
presume that p150 once formed can also act in trans as
a protease, since the 39-end mutant polyprotein (pSFV/
D90) containing part of the p90 was found to be able to
act in trans (Fig. 4C), and this trans cleavage activity was
abolished when the 59-end region including the x domain
(residues 1 to 918) was deleted (Fig. 4D). It is tempting to
speculate that the x domain might be involved in the
regulation of polyprotein processing. Further studies of
the capabilities of proteins individually expressed to
function as protease and of RV mutants that are unable
to cleave the polyprotein will be instructive.
MATERIALS AND METHODS
Cells and viruses
BHK-21 and Vero cells were grown in Eagle’s minimum
essential medium (MEM) supplemented with 10% fetal
bovine serum (FBS), penicillin (100 units/ml), and strep-
tomycin (50 mg/ml). RV (M33 strain) was propagated in
Vero cells and isolated from the culture supernatant as
described previously (Clarke et al., 1987).
Cloning and sequencing of RV ns protein genes
Intracellular total RNA from RV-infected Vero cells was
isolated at 72 h postinfection (m.o.i. 5 0.1). The isolated
cellular RNAs were used in first-strand cDNA synthesis
with random deoxyhexamer as primers (Rice et al., 1985).
FIG. 6. Immunoprecipitation of cytoplasmic extracts from RV-infected
Vero cells in the presence or the absence of E-64 and E-64C. Mono-
layers of Vero cells mock-infected (lanes 1 and 5) or RV-infected (lanes
2 to 4 and 6 to 9) were treated with E-64 (lanes 1, 3, 5, and 8) or E-64C
(lanes 4 and 9) for 90 min at 48 h pi and labeled with [35S]methionine/
cysteine for 2.5 h. After a 2.5-h chase, monolayers were lysed, and
cellular lysates were immunoprecipitated with antisera NS1 (lanes 1 to
4) or NS5 (lanes 5 to 9). The position of RV-specific ns proteins is
indicated on the right. The molecular weight standards (in kDa) are
indicated on the left. E-64 and E-64C were dissolved in dimethyl
sulfoxide. The concentration of dimethyl sulfoxide in the incubation was
3% (except in lane 6, in which no dimethyl sulfoxide was added).
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The cDNA fragments were amplified using the polymer-
ase chain reaction (PCR) (Erlich, 1989) with Taq DNA
polymerase and synthetic oligonucleotides designed ac-
cording to the sequence of RV Therien strain (Dominguez
et al., 1990). Nine PCR fragments isolated by agarose gel
electrophoresis were treated with T4 DNA polymerase
and inserted into the SmaI site of the M13mp19 vector.
The orientations of the inserts in positive clones were
identified by complementary tests using M13 superna-
tant phages (Messing, 1983).
For sequencing, single-stranded DNA in both orienta-
tions was prepared for each clone. Universal M13 primer
and synthetic oligonucleotides corresponding to appro-
priate regions of ns protein genes were used in sequenc-
ing. In some cases, sequencing reactions were carried
out at 75°C using Taq DNA polymerase to avoid prob-
lems caused by the secondary structure of the template.
Sequencing was performed on an ABI automated DNA
sequencer (Applied Biosystems Inc). Both the dye-primer
and dye-terminator kits were used in the sequencing
reaction. For some regions of DNAs, manual sequencing
(Sanger et al., 1977) was used to confirm ambiguities in
the sequence. Sequence analysis was performed using
DNA Strider program (Marck, 1988). The complete nucle-
otide sequence for nonstructural protein genes of RV
(M33 strain) is deposited in Gene Bank under Accession
No. X72393RVM33NP.
Determination of the 59-terminal sequence
of virion RNA
RV particles were isolated from culture supernatants
(50 ml) of RV-infected Vero cells by the conventional
polyethylene glycol precipitation (Bowden and West-
away, 1984). Pelleted RV particles were resuspended in
0.5 ml TNE buffer (10 mM Tris–HCl, pH 7.5; 150 mM NaCl;
1 mM EDTA), and virion RNA was extracted with Trizol
reagent (Gibco/BRL). First-strand cDNA synthesis was
carried out at 42°C for 1 h in a 20-ml reaction mixture
containing virion RNA, 0.5 mg random hexamer (Pro-
mega), 200 units of superscript RT RNase H2 reverse
transcriptase, and 40 units of RNasin (Promega) in a
buffer provided by the manufacturer (Gibco/BRL). The
synthesized cDNA was purified using a Qiaquick PCR
purification kit (Qiagen Inc) and then 39-terminally tailed
with dATP by using terminal deoxynucleotidyltransferase
(Boehringer Mannheim Biochemicals). The poly(A)-tailed
cDNA was extracted with phenol/chloroform, precipi-
tated with ammonium acetate, and used as a template
for the following amplification. A cDNA fragment of about
80 nucleotides containing a poly(A) tail was amplified in
a 50-ml PCR reaction mixture containing an upstream
oligonucleotide with a poly(T) tract (59-GAATTCAAGT17-
39), a downstream oligonucleotide (59-CCTCATCTAG-
GAGTTTC-39), complementary to the RV genome at nu-
cleotides 46 to 61), and 2 units of Vent (exo2) DNA
polymerase (New England Biolabs) in a buffer provided
by the manufacturer. The amplification consisted of one
cycle of 1 min at 95°C; 2 cycles of 30 s at 50°C, 1 min at
70°C; and 33 cycles of 20 s at 95°C, 20 s at 50°C, and
40 s at 70°C. The amplified fragments were purified with
a Qiaquick PCR purification kit and cloned into the SmaI
site of the pSU18 vector (Martinez et al., 1988). Three
clones were sequenced using the downstream oligonu-
cleotide that was used in the PCR reaction as a primer in
dideoxy sequencing (Sanger et al., 1977). The comple-
mentary DNA sequence obtained is shown in Fig. 1.
Peptide synthesis and rabbit immunization
Six synthetic peptides within ns protein (NS1, residues
1–36; NS2, residues 614–648; NS3, residues 1003–1033;
NS4, residues 1272–1307; NS5, residues 1598–1637; and
NS6, residues 1900–1933) (Fig. 2) were synthesized in an
ABI 430A automated peptide synthesizer using solid-
phase methods (Merrifield, 1969). Synthesized peptides
were cleaved from the resin by treatment with hydrogen
fluoride and purified by reverse-phase high-pressure liq-
uid chromatography using a Vydac C4 column. The purity
of all peptide preparations exceeded 95%. For each pep-
tide, amino acid analysis was performed on a Waters
Pico-tag system and found to be in good agreement with
the theoretical composition.
To prepare peptide-specific antisera, New Zealand
white rabbits (two rabbits for each peptide) were immu-
nized intramuscularly with each peptide (500 mg per
rabbit) emulsified in Freund’s complete adjuvant. On
days 21, 52, 82, 112, and 142, each rabbit received
booster injections with the same amount of respective
immunogen in incomplete Freund’s adjuvant. Rabbit sera
were collected 2 weeks after the final booster injection.
RNA transcription and transfection
The cDNA encoding the full-length RV ns protein-ORF
(Fig. 2) was inserted into the SmaI site of the pSFV-1
vector (BRL). This construct was named pSFV/RVnsp.
The plasmid pSFV/RVnsp was linearized at the SpeI site,
and the linearized DNA was used as the template for in
vitro transcription by standard protocols (Promega Corp)
using each nucleoside triphosphate and mG(5)pp(5)G at
final concentrations of 1 mM each. BHK-21 cells (0.5 ml,
107 cells/ml) were transfected with transcribed RNA by
electroporation (Liljestrom and Garoff, 1991). The elec-
troporated cells were suspended in 10 ml MEM contain-
ing 10% FBS and seeded in a 6-well culture plate.
Metabolic labeling
Transfected BHK cells. BHK cells at 24 h posttransfec-
tion were washed once with D-MEM lacking methionine
and cysteine. Then 5 ml of D-MEM containing 3% dia-
lyzed FBS but lacking methionine and cysteine was
added. After 30 min incubation at 37°C, 35S-protein la-
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beling mix (1175 Ci/mmol, NEN) was added to the me-
dium at a concentration of 100 mCi/ml and the incubation
was continued for 40 min. In pulse–chase experiments,
at the end of labeling period, the medium containing the
radiolabel was removed, and D-MEM containing the nor-
mal concentrations of methionine and cysteine was
added. Following the completion of the labeling and
chase period, the monolayers were washed three times
with PBS and scraped into 1 ml PBS. The cells were spun
down and resuspended in TNE buffer (10 mM Tris–HCl,
pH 7.5; 150 mM NaCl; 1 mM EDTA; and 10 mM phenyl-
methylsulfonyl fluoride) containing 1% SDS.
RV-infected Vero cells. Subconfluent monolayers of
Vero cells grown in 60-mm petri dishes were mock-
infected or infected with RV at a m.o.i. of 0.5 PFU/cell. At
24 or 48 h postinfection, monolayers were washed with
PBS twice and covered with D-MEM lacking methionine
and cysteine. Following incubation for 45 min at 37°C,
35S-protein labeling mix (1175 Ci/mmol, NEN) was added
to the medium at the concentration of 100 mCi/ml and
then further incubated for an additional 3 h. For pulse–
chase experiments, the protocol was the same as de-
scribed above in transfected BHK cells.
Immunoprecipitation
Rabbit anti-peptide serum was preincubated with Pro-
tein A–Sepharose (Pharmacia) for 2 h in binding buffer
(100 mM Tris–HCl (pH 7.4), 400 mM NaCl) with constant
mixing at room temperature. The serum-coated beads
were washed twice with binding buffer and once in lysis
buffer (25 mM Tris–HCl (pH 7.4), 100 mM NaCl, 1 mM
EDTA, 1% Nonidet P-40). 35S-Labeled cell lysate was
mixed with the coated beads overnight at 4°C in lysis
buffer. Beads were washed once with lysis buffer; twice
with wash buffer (25 mM triethanolamine; 172 mM NaCl;
1% deoxycholate; 0.1% SDS; 1 mM EDTA; pH 7.4); once
with 10 mM Tris–HCl (pH 7.4); and once with water.
Immunocomplexes were dissociated from the Protein
A–Sepharose by boiling in 100 mM sodium citrate (pH
5.5), 0.15% SDS for 5 min, vortexing, and pelleting the
beads by centrifugation.
To determine the coprecipitation of host proteins with
RV ns proteins, immunoprecipitation of cellular lysates
from RV-infected Vero cells was performed as described
by Wahlberg et al., (1989). Briefly, at the end of the pulse
or chase period, monolayers were washed twice with
PBS and lysed with buffer containing 50 mM Tris–HCl
(pH 7.4), 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40
(NP-40), and 74 mM antipain dihydrochloride (Boehringer-
Mannheim). Peptide antisera-coated Protein A–Sepha-
rose was washed with lysis buffer and incubated with
35S-labeled cellular lysates overnight at 4°C. Beads were
washed twice with washing buffer containing 10 mM
Tris–HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, and 0.2%
NP-40, and once with 10 mM Tris–HCl (pH 7.4). Immuno-
complexes were eluted as described above.
Construction of mutants
Two mutant plasmids (pSFV/Cys-1151 and pSFV/Gly-
1300) were constructed by using oligonucleotide-di-
rected mutagenesis on a single-stranded uracil-contain-
ing template (Kunkel et al., 1987). The fragment (SphI/
XbaI) from pSFV/RVnsp (Fig. 2) was isolated and
subcloned into the phage vector M13mp18 which had
been digested with SphI and XbaI restriction enzymes.
Mutagenic oligonucleotides were 59-GACCCAAACAC-
CAGCTGGCTCCGCGCC-39 (nucleotides 3494 to 34508)
and 59CTGTCTCGGGGCAGCGGCACTTGTGCC-39 (nu-
cleotides 3929 to 3958), respectively, for Cys-1151 to
serine and Gly-1300 to serine mutations (mutated bases
are underlined). After verification of the introduced mu-
tation by DNA sequencing, the SphI/XbaI fragment con-
taining the introduced mutation was recloned into the
pSFV/RVnsp plasmid (minus the original SphI/XbaI frag-
ment). pSFV/Cys-1151 carried the cysteine to serine mu-
tation at residue 1151, and pSFV/Gly-1300 had the glycine
residue at 1300 changed to serine (Fig. 2).
The deletion mutant (pSFV/D90) was constructed by
deletion of the BgIII/HindIII fragment (nucleotides 5352
to 6494) from pSFV/RVnsp (Fig. 2). The stop codon cas-
sette in the pSFV-1 vector was used in this construct. To
create a deletion mutant (pSFV/D150, deletion of nucle-
otides 39 to 2794), the NcoI fragment (nucleotides 39 to
4020) was first removed from the pSFV/RVnsp (Fig. 2) and
then ligated with the Nhe/NcoI fragment (nucleotides
2800 to 4020) containing a NcoI site at the 59 end of the
NheI site. For production of the NheI/NcoI fragment, the
upstream primer was 59-ATTCCCATGGTCGCGCTAGC-
GCC-39 (NcoI and NheI sites are underlined) and the
downstream primer was 59-GTAGGTGGCGGCGTTCTT-
GAT-39 (nucleotides 4217 to 4237). The amplified PCR
product was digested with NcoI prior to ligation.
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